Zyban-- is there a cause for concern?
by
Tracey JA.
Expert Opin Drug Saf. 2002 Nov;1(4):303-5


ABSTRACT

Bupropion hydrochloride is a monocyclic antidepressant which is used in a slow-release formulation as a smoking cessation aid. Its side effects include insomnia and dry mouth with seizures occurring in 1 in 1000 patients. In overdose, it can cause tachycardia, conduction defects and convulsions. It is, however, effective in smoking cessation in approximately 20% of patients and may be more effective if combined with nicotine replacement therapy. The key question is whether the risks associated with the drug are justified by the obvious benefits to health from smoking cessation.
Zyban
Tobacco
Bupropion SR
Zyban/smoking
Antidepressants: nicotine
Bupropion and depression
Bupropion for nicotine quitters
Bupropion, amphetamine and cigarettes
Quitting smoking: the role of antidepressants
Bupropion enhances pleasure for smokers who quit
Varenicline (Chantix) vs bupropion SR for tobacco addicts


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family